Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation

✍ Scribed by Orla Cunningham; Suzanne Campion; V. Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 567 KB
• Volume: 57
• Category: Article
• ISSN: 0894-1491
• DOI: 10.1002/glia.20892

✦ Synopsis

Abstract

The urokinase plasminogen activator (uPA) receptor (uPAR) is a GPI‐linked cell surface protein that facilitates focused plasmin proteolytic activity at the cell surface. uPAR has been detected in macrophages infiltrating the central nervous system (CNS) and soluble uPAR has been detected in the cerebrospinal fluid during a number of CNS pathologies. However, its expression by resident microglial cells in vivo remains uncertain. In this work, we aimed to elucidate the murine CNS expression of uPAR and uPA as well as that of tissue plasminogen activator and plasminogen activator inhibitor 1 (PAI‐1) during insults generating distinct and well‐characterized inflammatory responses; acute intracerebral lipopolysaccharide (LPS), acute kainate‐induced neurodegeneration, and chronic neurodegeneration induced by prion disease inoculation. All three insults induced marked expression of uPAR at both mRNA and protein level compared to controls (naïve, saline, or control inoculum‐injected). uPAR expression was microglial in all cases. Conversely, uPA transcription and activity was only markedly increased during chronic neurodegeneration. Dissociation of uPA and uPAR levels in acute challenges is suggestive of additional proteolysis‐independent roles for uPAR. PAI‐1 was most highly expressed upon LPS challenge, whereas tissue plasminogen activator mRNA was constitutively present and less responsive to all insults studied. These data are novel and suggest much wider involvement of the uPAR/uPA system in CNS function and pathology than previously supposed. © 2009 Wiley‐Liss, Inc.